Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients.

Saved in:
Bibliographic Details
Title: Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients.
Authors: Bakr S; Clinical Pathology/ Hematology, Faculty of Medicine, Fayoum University, Fayoum, Egypt. Electronic address: Sbm00@fayoum.edu.eg., Salem KM; Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt., Rashed AM; Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt., Tantawy MEA; Faculty of Medicine, Menoufia University, Egypt., Elsary AY; Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt., Shamardl HA; Medical Pharmacology, Faculty of Medicine, Fayoum University, Fayoum, Egypt., Ezzat EM; Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Source: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2024 Nov; Vol. 46 Suppl 5, pp. S214-S222. Date of Electronic Publication: 2024 Aug 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2531-1387
DOI:10.1016/j.htct.2024.04.125